Wolfe, B M <br/><br/>
Impact on postmenopausal symptoms of adding continuous C-21 versus C-19 progestin to estrogen.  [electronic resource] 

 -  Maturitas  Oct 1999 
 - 153-61 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0378-5122 
<br/><br/><label>Standard No.: </label>10.1016/s0378-5122(99)00053-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adverse Drug Reaction Reporting Systems<br/>Climacteric--drug effects<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Estrogen Replacement Therapy<br/>Female<br/>Humans<br/>Medroxyprogesterone Acetate--administration & dosage<br/>Middle Aged<br/>Norgestrel--administration & dosage<br/>Prospective Studies